MSD Animal Health

What MSD Animal Health does

MSD Animal Health is the global animal health division of Merck & Co., Inc. (NYSE: MRK), operating commercially across more than 50 countries. The French subsidiary, MSD Santé Animale, is headquartered in Beaucouzé (Angers) and serves as the company's commercial and technical-support node for the French market. The business develops, registers, manufactures, and markets veterinary pharmaceuticals, vaccines, identification and monitoring technologies, and a growing suite of digital tools for animal health professionals and animal owners.

The product portfolio spans companion animals (Bravecto parasiticide franchise, Nobivac vaccines, Panacur, Azium, Regumate), livestock (Bovilis vaccine range including Rotavec Corona, Finadyne NSAID, AquaVac, Calcitat Fort, Oxytetrin P), and additional species coverage. The division was built on Intervet (founded 1969, acquired by Merck in 2007) and has been progressively rebranded and expanded under the MSD Animal Health identity. Beyond products, MSD operates a digital ecosystem including the Mon MSD practitioner portal, Venotis, Happy Poule (poultry producers), Rappels MSD, Tout Pour Ma Clinique, PetCheck, CMV, and the Club ASV community for veterinary auxiliaries (founded 2014). Recent regulatory milestones include Bravecto injectable launch (July 2024), Finadyne expanded cattle indications (November 2024), and BOVILIS Rotavec Corona subcutaneous approval (December 2024).

The business model is B2B-led with multi-channel reach. Revenue is generated primarily through sales of prescription pharmaceuticals and vaccines to veterinary practitioners, livestock farmers, and equine professionals, with secondary consumer-facing engagement via pet-owner digital tools. Go-to-market combines direct veterinary sales, distribution partnerships, and digital service layers that deepen practitioner and producer relationships. Customer segments are diversified across companion-animal practices, bovine/ovine/poultry producers, and equine operations, with veterinary auxiliaries (ASVs) addressed through the dedicated Club ASV community. The MSD Animal Health division sits within Merck's broader pharmaceutical portfolio and benefits from corporate R&D, regulatory, and commercial infrastructure.

Name

MSD Animal Health

Legal name

MSD Santé Animale

Website

https://msd-sante-animale.fr

Company type

Public

Founded year

1969

Operating status

Operating

Headcount range

11–50 employees

Short description

MSD Animal Health, the global animal health division of Merck & Co., develops and markets veterinary pharmaceuticals, vaccines, and digital tools for veterinarians, livestock farmers, and animal owners across more than 50 countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals and Animal Health

NAICS

Veterinary Services (54194), Veterinary Services (541940)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Vaccination, Parasite Control & Immunization Programs (AFACADAG), Pharmacy, Biologics & Veterinary Supply Dispensing (Farm Animal) (AFACADAM), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Veterinary Vaccines (HLAIAEAH), Veterinary Vaccine & Biologics Distributors (HLAMAIAC)

Keywords

• Veterinary pharmaceuticals
• Animal vaccines
• Livestock health solutions
• Companion animal care
• Veterinary digital ecosystem

Headquarters

HQ city

Beaucouzé

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations, Others

Revenue model

1. Veterinary Pharmaceuticals and Vaccines: Sale of veterinary medicines, vaccines, and biological products for prevention and treatment of diseases in production animals (ruminants, pigs, poultry, horses) and companion animals (dogs, cats, rabbits). MSD Animal Health commercializes more than 200 products in France alone.
2. Identification and Monitoring Technologies: Sale of animal identification and monitoring technology solutions that enable tracking and health management of livestock and companion animals.
3. E-commerce Platform Sales: Direct online sales of animal health products through the MSD Santé Animale e-shop, reserved for licensed veterinarians and their authorized purchasers.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

MSD Animal Health (MSD Santé Animale) develops, manufactures, and commercializes veterinary pharmaceuticals, vaccines, and animal health solutions for production animals (cattle, pigs, poultry, sheep, horses, fish) and companion animals (dogs, cats, rabbits). The company sells more than 200 products in France alone across ectoparasiticides, vaccines, anti-inflammatories, anthelmintics, antibiotics, hormonal treatments, and identification/monitoring technologies. It complements these products with a digital ecosystem of veterinary client portals, SMS reminder services, herd management tools, professional communities, and an e-commerce platform restricted to licensed veterinarians.

Product overview

MSD Animal Health is one of the global leaders in animal health, offering a broad and innovative portfolio of veterinary medicines and animal identification and monitoring technology solutions. The company commercializes over 200 products in France alone, covering both production animals (cattle, sheep, goats, pigs, poultry, fish) and companion animals (dogs, cats, rabbits, horses). Their product portfolio is organized around three pillars: biopharmaceutical solutions (vaccines, anti-parasitics, anti-inflammatories, antibiotics, and hormonal treatments), technological solutions (identification and monitoring devices), and a digital ecosystem. Key product brands include Bravecto (ectoparasiticides), Bovilis (vaccines), Panacur (anthelmintics), Finadyne (NSAIDs), Nobivac (vaccines), Calcitat Fort (nutritional supplements), and Oxytetrin P (antibiotics). The digital ecosystem includes Mon MSD (veterinary client portal), Rappels MSD (SMS reminders), Venotis (farm management), Happy Poule (poultry monitoring), Tout Pour Ma Clinique (business services), Club ASV (veterinary assistant community), Campus du Management Vétérinaire (educational resources), and PetCheck (pet owner app).

Differentiator

Problem solved

Functional benefit

Brands

• Mon MSD: Online application reserved for veterinary clients providing access to a vast library of content, documentation, training videos, and webconference replays.
• Club ASV
• Campus du Management Vétérinaire (CMV)
• Mon MSD
• Rappels MSD
• Venotis
• Happy Poule
• Tout Pour Ma Clinique

Products and services

• Bravecto

Quantifiable outcome

• Over 200 products commercialized in France
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Fédération des Vétérinaires d'Europe (FVE)coreStrategic or Co-development Partner · 14 February 2024MSD Animal Health partners with FVE on an annual scholarship program for veterinary students. In 2024, the program rewarded 34 students from across Europe, demonstrating commitment to supporting the next generation of veterinary professionals and strengthening ties with the European veterinary community.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Elanco Animal Health: Independent animal health company (now including Dechra) competing across companion animal therapeutics, livestock vaccines, and parasiticides. Comparable breadth and distribution channels in France and across Europe.
• Ceva Santé Animale: French multinational animal health group specializing in vaccines, pharmaceuticals, and equipment for livestock and companion animals. Direct French peer with comparable product mix and veterinary distribution model.
• Vetoquinol: Independent French animal health company focused on livestock and companion animal pharmaceuticals. Competes with MSD across the French vet channel and exports broadly across Europe and emerging markets.
• Virbac: French-headquartered global animal health company focused on companion animals and livestock pharmaceuticals, vaccines, and diagnostics. A particularly close French-market peer to MSD Santé Animale with overlapping vet-channel customers.
• Dechra Pharmaceuticals: Specialty animal health company (now part of Elanco) known for companion animal endocrinology, dermatology, and critical care. Comparable companion-animal pharmaceutical focus to MSD's Bravecto and related pet lines.
• Zoetis: The largest pure-play global animal health company, competing with MSD across vaccines, parasiticides, anti-infectives, and diagnostics for both livestock and companion animals. Most directly comparable competitor in product breadth and category coverage.
• Boehringer Ingelheim Animal Health: Top-three global animal health player offering vaccines, parasiticides, and pharmaceuticals across livestock and pets, with a particularly strong companion animal vaccines portfolio. Directly competes with MSD's Bovilis, Nobivac, and Bravecto franchises.

Emerging players

• Bimeda: Global animal health manufacturer with a broad generics and branded portfolio in livestock and equine health. Competes in segments adjacent to MSD's mature livestock franchises such as Panacur and Finadyne.
• Animalcare: European animal health company with companion animal and livestock products, including parasiticides and identification technologies that overlap with MSD's Bravecto and monitoring offerings.

Broad incumbents

• IDEXX Laboratories: Dominant veterinary diagnostics and practice software company serving the same veterinarian customer base as MSD. Complementary rather than directly substitutive, but competes for share of vet wallet and digital engagement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/MSDsanteanimale
• YouTubeyoutube.com/user/MSDsanteanimale
• Facebookfacebook.com/MSD.santeanimale
• LinkedInlinkedin.com/company/msd-sant%C3%A9-animale-france

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSD Animal Health